John Johnson, MD
Hospitalist · Seneca, SCNPI 1699764555
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,400 of the $7,221 with a category attached, or 74.8%. Neurocrine Biosciences, Inc. accounts for 86.1% of it on its own, with 7 other manufacturers making up the rest. 2024 is the largest year on record at $6,450, more than ten times the $190 reported in 2019. Among hospitalist clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 26 payments — averaging $277.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$6K
- Pfizer$429
- Abbott$199
- Biotissue Holdings Inc.$141
- Otsuka Pharmaceutical Development & Commercialization, Inc.$124
- AstraZeneca$63
- plus $48 from 2 others
What the payments were for
- Consulting fees$5,40075%
- Travel & lodging$4326%
- Food & beverage$1,38919%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 8 | $6,216 |
| Pfizer | 3 | $429 |
| Abbott | 6 | $199 |
| Biotissue Holdings Inc. | 1 | $141 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $124 |
| AstraZeneca | 4 | $63 |
| Novo Nordisk | 2 | $35 |
| Medline Industries LP | 1 | $13 |
How this compares
$7,221 in reported general payments places this provider in the 95th percentile of 398 hospitalist providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 14 | $124 |
| Allopurinol | 14 | $79 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Seneca
- Joseph OgunsulireSeneca$28K
- Nathaniel RichardsSeneca$950
- Erika KingMyrtle Beach$19K
- Woodrow CokerCharleston$14K
- Patrick CawleyCharleston$10K
- Christopher VagnoniAnderson$9K
- Anthony ZamchoWest Columbia$7K
- Michael WagnerGreenville$4K
- Phillip WarrCharleston$3K
- Danielle ScheurerCharleston$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.